15 Pages Posted: 30 Nov 2016 Last revised: 6 Jan 2017
Date Written: November 28, 2016
This report discusses data suggesting that ulterior profit motives may be at the heart of the recent increase in pharmaceutical philanthropy carried out through patient assistance programs (PAPs). The author argues that further research is necessary to explore the cost burden PAPs impose on public payers.
Keywords: Corporate Charity, Pharmaceutical, Patient Assistance Programs, PAPs
JEL Classification: G30, H25
Suggested Citation: Suggested Citation
Frerick, Austin, The Cloak of Social Responsibility: Pharmaceutical Corporate Charity (November 28, 2016). Tax Notes, Vol. 153, Number 9, P. 1151, 2016. Available at SSRN: https://ssrn.com/abstract=2874391